ELL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.559800E-01
Normal-vs-Stage2
7.426000E-01
Normal-vs-Stage3
7.593000E-01
Normal-vs-Stage4
9.273600E-01
Stage1-vs-Stage2
9.164600E-01
Stage1-vs-Stage3
9.028000E-01
Stage1-vs-Stage4
6.377600E-01
Stage2-vs-Stage3
7.780800E-01
Stage2-vs-Stage4
6.076200E-01
Stage3-vs-Stage4
6.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.541600E-01
Normal-vs-AfricanAmerican
4.243200E-01
Normal-vs-Asian
6.874400E-01
Caucasian-vs-AfricanAmerican
3.865600E-01
Caucasian-vs-Asian
8.216400E-01
AfricanAmerican-vs-Asian
5.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.305200E-01
Normal-vs-Female
7.564200E-01
Male-vs-Female
8.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.451200E-01
Normal-vs-Age(41-60Yrs)
8.969200E-01
Normal-vs-Age(61-80Yrs)
5.852800E-01
Normal-vs-Age(81-100Yrs)
6.218000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.224800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.495800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.799020E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.503600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.699570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.351400E-01
Normal-vs-Daily Drinker
6.962400E-01
Normal-vs-Weekly Drinker
9.299800E-01
Normal-vs-Occasional Drinker
9.346600E-01
Normal-vs-Social Drinker
4.520200E-01
Non Drinker-vs-Daily Drinker
7.996600E-01
Non Drinker-vs-Weekly Drinker
2.926200E-01
Non Drinker-vs-Occasional Drinker
3.815000E-01
Non Drinker-vs-Social Drinker
8.759400E-01
Daily Drinker-vs-Weekly Drinker
3.937000E-01
Daily Drinker-vs-Occasional Drinker
5.196000E-01
Daily Drinker-vs-Social Drinker
6.762800E-01
Weekly Drinker-vs-Occasional Drinker
7.586800E-01
Weekly Drinker-vs-Social Drinker
2.135000E-01
Occasional Drinker-vs-Social Drinker
2.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.957000E-01
Normal-vs-Grade 2
6.170200E-01
Normal-vs-Grade 3
6.341200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.330400E-01
Grade 1-vs-Grade 3
4.791200E-01
Grade 1-vs-Grade 4
3.957000E-01
Grade 2-vs-Grade 3
6.886600E-01
Grade 2-vs-Grade 4
6.170200E-01
Grade 3-vs-Grade 4
6.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.687000E-01
Normal-vs-NonDiabetic
7.249400E-01
Diabetic-vs-NonDiabetic
6.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.377400E-01
Normal-vs-NoPancreatitis
7.662400E-01
Pancreatitis-vs-NoPancreatitis
8.172000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.365600E-01
Normal-vs-N1
7.672600E-01
N0-vs-N1
4.240400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.072400E-02
Normal-vs-TP53-NonMutant
2.580400E-01
TP53-Mutant-vs-TP53-NonMutant
6.637200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
